Search Results for the EPA National Library Catalog

Items Found: 584
Showing: Items 451 - 500
Your Search: (SUBJECT=Drugs)


 
 
 
PREV 1 2 3 4 5 6 7 8 9 10 11 12 NEXT
Select Item Title Year Published
Plant drug analysis : a thin layer chromatography atlas 1984
Poisoning & drug overdose 1990
Pollution prevention assessment for a manufacturer of pharmaceuticals / 1995
Potential carcinogenicity of nitrosatable drugs : WHO symposium, Geneva, June 1978 1980
Potentiation of Phosphorus Insecticides by Phenothiazine Derivatives: Possible Hazard, with Report of a Fatal Case. 1962
PPCPs and EDCs : occurrence in the Detroit River and their removal by ozonation / 2009
Practical concepts for dose selection in chronic toxicity and carcinogenicity studies in rodents. 1996
Predictive toxicometrics basic methods for estimating poisonous amounts of foods, drugs, and other agents / 1972
Preliminary data summary for the pharmaceutical manufacturing point source category. 1989
Prenatal drug exposure : kinetics and dynamics / 1985
Prescription drug use among adults aged 40-79 in the United States and Canada / 2019
Prescription drugs 1986
Primer of drug action : a concise, nontechnical guide to the actions, uses, and side effects of psychoactive drugs / 1995
Primer of drug action : a concise, nontechnical guide to the actions, uses, and side effects of psychoactive drugs / 1998
Principles for evaluating health risks to progeny associated with exposure to chemicals during pregnancy 1984
Principles for modelling dose-response for the risk assessment of chemicals / 2009
Principles for the clinical evaluation of drugs; report of a WHO Scientific Group. 1968
Principles for the testing and evaluation of drugs for carcinogenicity; report of a WHO Scientific Group. 1969
Principles of biochemical toxicology 1982
Principles of drug action; the basis of pharmacology 1973
Proceedings of the ... International Symposium on Controlled Release of Bioactive Materials. 0
Proceedings of the Workshop on Test Methods for Definition of Effects of Toxic Substances on Behavior and Neuromotor Function / 1979
Product safety evaluation 1983
Progress in drug metabolism. 1976
Proposed best demonstrated available technology (BDAT) background document for miscellaneous halogenated organic wastes of a pharmaceutical nature, brominated organic wastes, organo-sulfur compound wastes, and organo-nitrogen compound wastes. : Volume 7 / 1989
Proteomics in drug research 2006
Psychopharmacological agents. 1964
QSAR & combinatorial science. 2003
QSAR and strategies in the design of bioactive compounds : proceedings of the Fifth European Symposium on Quantitative Structure-Activity Relationships, Bad Segeberg, 1984 / 1985
Quantitation and mass spectrometric data of drugs and isotopically labeled analogs / 2010
Quantitative aspects of chemical pharmacology chemical ideas in drug action with numerical examples / 1980
Quantitative mass spectrometry in life sciences II proceedings of the second international symposium held at the State University of Ghent, June 13-16, 1978 / 1978
Quantitative structure-activity relationships including molecular modelling and applications of computer graphics in pharmacology, chemistry, and biology : QSAR. 1985
Quantitative structure-activity relationships. 1985
Radiological Health Aspects of Agents Modifying the Biological Effects of Radiation. 1969
Rate-controlled drug administration and action 1985
Re-inventing drug development / 2015
Recent developments in mass spectrometry in biochemistry and medicine 1979
Reciprocal Relationship Between the Induction of delta-Aminolevulinic Acid Synthetase and Drug Metabolism Produced by m-Dichlorobenzene. 1970
Reference Physiological Parameters in Pharmacokinetic Modeling. 1988
Relation of Molecular Connectivity to Molecular Volume and Biological Activity. 1981
Remington : the science and practice of pharmacy. 2006
Removal and fate of EDCs and PPCPs in bank filtration systems / 2010
Removal of EDCs and pharmaceuticals in drinking and reuse treatment processes 2007
Reproductive toxicology 1985
Reserpine in the treatment of neuropsychiatric, neurological, and related clinical problems 1955
Response Artifact in the Measurement of Neuroleptic-Induced Anhedonia. 1981
Roach's introductory clinical pharmacology / 2018
Saliva as a diagnostic fluid 1993
SAR : side effects and drug design / 1987
PREV 1 2 3 4 5 6 7 8 9 10 11 12 NEXT

Save, Print or Email Selected Records